Chamberlain ///
NR
/ ///
325
/ ///
Exam 2 Questions With Correct Answers
/ //// //// //// //// ////
Which ///
/sided ///
/stroke ///
/has ///
/impaired ///
/speech/language ///
/aphasia; ///
/impaired ///
/right/left ///
/discrimination; ///
/slow ///
/performance/cautious,; ///
/depression/anxiety; ////impaired ////comprehension. ////- ////CORRECT ////ANSWERS(S)✔✔Left-Sided
Which ///
/sided ///
/stroke ///
/has ///
/spatial ///
/perception ///
/deficits; ///
/denying/minimizing; ///
/rapid ///
/performance/short ///
/attention; ///
/impulsiveness; ///
/impaired ////judgment; ////impaired ////time. ////- ////CORRECT ////ANSWERS(S)✔✔Right-sided
,_____ ///
/are ///
/the ///
/confirming ///
/diagnostic ///
/studies ///
/for ///
/stroke. ////- ///
/CORRECT ///
/ANSWERS(S)✔✔CT; ///
/CT ///
/angiogram; ///
/CT/MRI ///
/perfusion ////and ////diffusion ////imaging; ////MRI; ////Magnetic ////resonance ////angiography ////(MRA)
_____ ///
/are ///
/the ///
/confirming ///
/laboratory ///
/studies ///
/for ///
/stroke. ////- ///
/CORRECT ///
/ANSWERS(S)✔✔Prothrombin ///
/time, ///
/activated ///
/partial ///
/thromboplastin ///
/time; ///
/CBC ///
/(including ///
/platelets); ///
/Electrolyte ////panel ////with ////blood ////glucose; ////Lipid ////profile; ////Renal ////and ////hepatic ////studies
,Recombinant ///
/tissue ///
/plasminogen ///
/activator ///
/(tPA) ///
/is ///
/used ///
/to ///
/produce ///
/localized ///
/fibrinolysis ///
/by ///
/binding ///
/to ///
/the ///
/fibrin ///
/in ///
/the ///
/thrombi, ///
/and ///
/is ///
/the ///
/immediate ///
/treatment ////for ////_____ ////_____. ////- ////CORRECT ////ANSWERS(S)✔✔Ischemic ////stroke
Aspirin ///
/at ////
a ///
/dose ///
/of ///
/325 ///
/mg ///
/may ///
/be ///
/started ///
/within ///
/24 ///
, /to ///
/48 ///
/hours ////after ////the ////onset ////of ////an ////_____ ////stroke. ////- ////CORRECT ////ANSWERS(S)✔✔ischemic
Anticoagulants ///
/and ///
/platelet ///
/inhibitors ///
/are ///
/contraindicated ///
/in ////patients ////with ////_____ ////strokes. ////- ////CORRECT ////ANSWERS(S)✔✔hemorrhagic
The ///
/main ///
/drug ///
/therapy ///
/for ///
/patients ///
/with ///
/_____ ///
/stroke ///
/is ////the ////management ////of ////hypertension. ////- ////CORRECT ////ANSWERS(S)✔✔hemorrhagic
The ///
/_____ ///
/_____ ///
/of ////
a ///
/spinal ///
/cord ///
/injury ///
/(SCI) ///
/is ///
/initial ///
/physical ////disruption ////of ////the ////spinal ////cord. ////- ////CORRECT ////ANSWERS(S)✔✔primary ////injury
NR
/ ///
325
/ ///
Exam 2 Questions With Correct Answers
/ //// //// //// //// ////
Which ///
/sided ///
/stroke ///
/has ///
/impaired ///
/speech/language ///
/aphasia; ///
/impaired ///
/right/left ///
/discrimination; ///
/slow ///
/performance/cautious,; ///
/depression/anxiety; ////impaired ////comprehension. ////- ////CORRECT ////ANSWERS(S)✔✔Left-Sided
Which ///
/sided ///
/stroke ///
/has ///
/spatial ///
/perception ///
/deficits; ///
/denying/minimizing; ///
/rapid ///
/performance/short ///
/attention; ///
/impulsiveness; ///
/impaired ////judgment; ////impaired ////time. ////- ////CORRECT ////ANSWERS(S)✔✔Right-sided
,_____ ///
/are ///
/the ///
/confirming ///
/diagnostic ///
/studies ///
/for ///
/stroke. ////- ///
/CORRECT ///
/ANSWERS(S)✔✔CT; ///
/CT ///
/angiogram; ///
/CT/MRI ///
/perfusion ////and ////diffusion ////imaging; ////MRI; ////Magnetic ////resonance ////angiography ////(MRA)
_____ ///
/are ///
/the ///
/confirming ///
/laboratory ///
/studies ///
/for ///
/stroke. ////- ///
/CORRECT ///
/ANSWERS(S)✔✔Prothrombin ///
/time, ///
/activated ///
/partial ///
/thromboplastin ///
/time; ///
/CBC ///
/(including ///
/platelets); ///
/Electrolyte ////panel ////with ////blood ////glucose; ////Lipid ////profile; ////Renal ////and ////hepatic ////studies
,Recombinant ///
/tissue ///
/plasminogen ///
/activator ///
/(tPA) ///
/is ///
/used ///
/to ///
/produce ///
/localized ///
/fibrinolysis ///
/by ///
/binding ///
/to ///
/the ///
/fibrin ///
/in ///
/the ///
/thrombi, ///
/and ///
/is ///
/the ///
/immediate ///
/treatment ////for ////_____ ////_____. ////- ////CORRECT ////ANSWERS(S)✔✔Ischemic ////stroke
Aspirin ///
/at ////
a ///
/dose ///
/of ///
/325 ///
/mg ///
/may ///
/be ///
/started ///
/within ///
/24 ///
, /to ///
/48 ///
/hours ////after ////the ////onset ////of ////an ////_____ ////stroke. ////- ////CORRECT ////ANSWERS(S)✔✔ischemic
Anticoagulants ///
/and ///
/platelet ///
/inhibitors ///
/are ///
/contraindicated ///
/in ////patients ////with ////_____ ////strokes. ////- ////CORRECT ////ANSWERS(S)✔✔hemorrhagic
The ///
/main ///
/drug ///
/therapy ///
/for ///
/patients ///
/with ///
/_____ ///
/stroke ///
/is ////the ////management ////of ////hypertension. ////- ////CORRECT ////ANSWERS(S)✔✔hemorrhagic
The ///
/_____ ///
/_____ ///
/of ////
a ///
/spinal ///
/cord ///
/injury ///
/(SCI) ///
/is ///
/initial ///
/physical ////disruption ////of ////the ////spinal ////cord. ////- ////CORRECT ////ANSWERS(S)✔✔primary ////injury
